Company intelligence
PharmaEssentia
Better Science, Better Lives.
Biotechnology Research
Burlington, US
478 employees
Founded 2003
2 public signals
About PharmaEssentia
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan, leveraging deep expertise and proven scientific principles to deliver new biologics in hematology, oncology, and immunology. Founded in 2003, PharmaEssentia is now expanding its global presence with operations in the U.S., Japan, China and Korea.
Verified activity
Signals from PharmaEssentia
2 published signals
Presence & Recognition
PharmaEssentia is hosting an upcoming MPN In Focus live event on October 3rd in Atlanta, GA and October 24th in Phoenix, AZ.
Reported by PharmaEssentia
Legal & Regulatory
PharmaEssentia received FDA approval for its treatment option for adults living with essential thrombocythemia (ET), marking the first FDA-approved treatment for ET in nearly 30 years.
Reported by PharmaEssentia